Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma

PURPOSE: It has been reported that circulating levels of IgG antibodies against p16, CD25 and FOXP3 proteins were significantly changed in patients with lung cancer, breast cancer and esophageal cancer. However, different peptide fragments appear to trigger different immune responses. This work aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiaxin, Xu, Yangchun, Wang, Yanjun, Zhang, Xuan, Zhang, Guizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897059/
https://www.ncbi.nlm.nih.gov/pubmed/31819529
http://dx.doi.org/10.2147/OTT.S226404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897059/
https://www.ncbi.nlm.nih.gov/pubmed/31819529
http://dx.doi.org/10.2147/OTT.S226404

Ejemplares similares